Question:Consider the following with respect to National Immunogenicity & Biologics Evaluation Center:
(1) It is a first of its kind centre in the country developed for evaluation of the immunogenicity of vaccines & antiviral properties of drugs/preparations.
(2) It has been established jointly by Bharati Vidyapeeth University and BIRAC-DBT.
Which is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) None of these
Answer:(c)
- Context:
- Department of Biotechnology(DBT) Secretary has inaugurated National Immunogenicity & Biologics Evaluation Center(NIBEC).
- Facts:
- About NIBEC: It is a first of its kind centre in the country developed for evaluation of the immunogenicity of vaccines & antiviral properties of drugs/preparations.
- Developed by: It has been established jointly by Bharati Vidyapeeth University through its constituent unit Interactive Research School for Health Affairs(IRSHA) and BIRAC-DBT through National Biopharma Mission.
- Additional Facts:
- National Biopharma Mission(NBM):
- It is an industry-academia collaborative mission for accelerating biopharmaceutical development in the country.
- Launched Year: It was launched in 2017 at a total cost of Rs 1500 crore and is 50% co-funded by World Bank loan.
- Implementation: Biotechnology Industry Research Assistance Council (BIRAC).
- Innovate in India(i3) programme: It has been launched under this mission to create an enabling ecosystem to promote entrepreneurship and indigenous manufacturing in the biopharma sector.
- BIRAC:
- It is a not-for-profit state owned enterprise under the Department of Biotechnology (DBT) to strategically empower emerging biotech companies.
By:Arpit Mishra
Link: